Loading…

GEMOAB MONOCLONALS GMBH NOVEL IMMUNOTHERAPEUTIC CONCEPTS - Owned by Cellex Gesellschaft für Zellgewinnung mbH - (Class 035, Class 042, Class 044) | Sealvo